Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natalizumab de-escalation to interferon-beta-1b in patients with relapsing-remitting multiple sclerosis
2012-004040-30Phase 4Completed
- Sponsor
- Ospedale Regionale di Lugano
- Start
- Mar 2013
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of interferon beta-1a in multiple sclerosis (MS), sponsored by Ospedale Regionale di Lugano. Started Mar 2013; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2012-004040-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004040-30.